Effects of dietary supplementation with in vitro-cultivated arboreal medicinal mushrooms on stress coping strategies, depressive and anxiety-like behaviour of rats.

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Preclinical studies show that an edible arboreal medicinal mushroom – Hericium erinaceus (HE), is neuroprotective against high corticosterone levels and modulates stress-coping strategies of rodents. Moreover, other arboreal mushrooms ( Fomitopsis officinalis , FO; and Pleurotus djamor , PDJ) had a similar effect. Here, we explored potential dose-dependency of the effects of dietary supplementation with HE, FO or PDJ on anxiety-like behaviours and stress-coping strategies in rats; and, compared them to a drug commonly prescribed for stress-related psychiatric disorders (fluoxetine, FLX; 20 mg/kg) to evaluate those effects quantitatively and qualitatively. For 3 weeks, male Wistar rats were given 0, 100, 250 or 500 mg/kg ( per os ) of HE, FO or PDJ lyophilizate obtained from in vitro cultures. Subsequently, animals were tested in the battery of behavioral tests: open field (OF), elevated plus maze (EPM) and forced swimming (FST) tests. Middle dose of FO increased rearing in OFT indicates reduced anxiety-like behavior in rodents, and swimming (while decreasing climbing) in FST indicate antidepressant-like and also anti-anxiety-like effects no worse or even superior to those of fluoxetine. At the same time, we concluded that the effects of medicinal mushroom supplementation on stress-related behaviours vary depending on the mushroom species and dosage regimen.

Article activity feed